PRESS RELEASE published on 09/09/2024 at 22:01, 2 years ago Abivax presents first-half 2024 financial results Abivax presents first-half 2024 financial results with a cash balance of EUR 222M at June 30, 2024. The company focuses on developing therapies for chronic inflammatory diseases Financial Results Abivax Therapeutics Chronic Inflammatory Diseases EUR 222M
PRESS RELEASE published on 09/09/2024 at 22:01, 2 years ago Abivax présente ses résultats financiers du premier semestre 2024 Abivax présente ses résultats financiers semestriels 2024 avec une trésorerie de 222 millions d'euros au 30 juin 2024, assurant le financement jusqu'au Q4 2025 Résultats Financiers Abivax Bilan Trésorerie Dépenses
BRIEF published on 08/29/2024 at 18:05, 2 years ago ABIVAX : État des actions et des droits de vote au 31 juillet 2024 Euronext Paris Droits De Vote Actions Abivax Réglementaire
BRIEF published on 08/29/2024 at 18:05, 2 years ago ABIVAX: Status of shares and voting rights as of July 31, 2024 Euronext Paris Voting Rights Actions Abivax Regulatory
PRESS RELEASE published on 08/29/2024 at 18:00, 2 years ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.07.24. ABIVAX annonce le nombre d'actions et de droits de vote au 31.07.24, conformément aux réglementations en vigueur Euronext Paris Droits De Vote Actions Abivax Règlement Général
BRIEF published on 08/06/2024 at 08:35, 2 years 1 month ago Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT Abivax Obefazimod Rectocolite Hémorragique Essai Clinique Recrutement Patients
BRIEF published on 08/06/2024 at 08:35, 2 years 1 month ago Abivax Reaches Key Milestone with Recruitment of 600 Patients for Phase 3 ABTECT Trial Patient Recruitment Abivax Obefazimod Ulcerative Colitis Clinical Test
PRESS RELEASE published on 08/06/2024 at 08:30, 2 years 1 month ago Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT, confirmant son avancement vers l'objectif de recrutement complet au premier trimestre 2025 Abivax Recrutement Essai Clinique Phase 3 ABTECT
PRESS RELEASE published on 08/06/2024 at 08:30, 2 years 1 month ago Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT, confirmant l'évolution favorable du projet. La société réaffirme ses prévisions pour 2025 Abivax Recrutement Traitement Phase 3 ABTECT
PRESS RELEASE published on 08/06/2024 at 08:30, 2 years 1 month ago Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone Abivax announces ABTECT Phase 3 Trial surpasses 600-patient enrollment milestone, on track for full enrollment by early Q1 2025. Trial trends align with previous observations Abivax Obefazimod Ulcerative Colitis ABTECT Phase 3 Trial Enrollment Milestone
Published on 09/22/2026 at 08:00, 1 hour 8 minutes ago Coretura Selects Alloy Kore to Advance a Unique Software-Defined Vehicle Platform for Its Commercial Vehicle Customers
Published on 09/22/2026 at 08:00, 1 hour 8 minutes ago Caledonia Mining Corporation PLC: Notification of Relevant Change to Significant Shareholder
Published on 09/22/2026 at 06:45, 2 hours 23 minutes ago Akkodis and Hamburg Public Transport Association Showcase hvv mia at InnoTrans 2026, Demonstrating the Future of AI-Powered Mobility
Published on 09/22/2026 at 06:45, 2 hours 23 minutes ago Akkodis et l’association des transports publics de Hambourg présentent hvv mia à InnoTrans 2026 et montrent comment l’IA transforme la mobilité.
Published on 09/22/2026 at 06:45, 2 hours 23 minutes ago Akkodis en Hamburger Verkehrsverbund presenteren hvv mia op InnoTrans 2026 en tonen de toekomst van AI-gedreven mobiliteit
Published on 09/22/2026 at 08:30, 38 minutes ago EQS-Adhoc: Katjes Greenfood resolves to issue a new corporate bond
Published on 09/22/2026 at 08:30, 38 minutes ago TAKKT AG: Stépan Breedveld to Take Over as Chairman of the Supervisory Board
Published on 09/22/2026 at 08:25, 43 minutes ago Breda University: how cycling infrastructure can unlock the future of urban mobility
Published on 09/22/2026 at 08:20, 47 minutes ago ExploRNA Therapeutics and Łukasiewicz - IChP Announce Strategic Partnership to Advance GMP Manufacturing of Next-Generation mRNA Cap Analogs
Published on 09/21/2026 at 18:19, 14 hours 49 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 14 au 18 septembre 2026
Published on 09/21/2026 at 18:19, 14 hours 49 minutes ago Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 15 hours 6 minutes ago Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 15 hours 22 minutes ago WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 17:46, 15 hours 22 minutes ago WEB SA - RESULTATS SEMESTRIELS STATUTAIRES AU 30/06/2026
